Cardiovascular Diseases Stem Cell Therapy Development
Stem cell therapy is an innovative and promising approach in the field of regenerative medicine aimed at repairing and regenerating damaged heart tissue. This therapy utilizes specialized cells called stem cells, which have the unique ability to develop into various types of cells in the body, including cardiac muscle cells (cardiomyocytes) and blood vessel cells. CD BioSciences offers stem cell therapy development services for CVD, based on out advanced technology and professional team.
Introduction into Cardiovascular Diseases
Cardiovascular diseases (CVDs) are a group of medical conditions that affect the heart and blood vessels, and they collectively represent one of the leading causes of death and disability worldwide. These diseases primarily involve the heart (cardio) and blood vessels (vascular), which include arteries, veins, and capillaries.
CVDs are highly prevalent and have a significant impact on public health. They affect people of all ages, genders, and backgrounds. And they are responsible for a substantial proportion of global deaths, with coronary artery disease (CAD) and stroke being the most common causes. CVDs can lead to serious health complications, reduced quality of life, and increased healthcare costs.
Stem Cell Therapy for Cardiovascular Diseases
A lot of stem cell types have been utilized in regenerative cardiac research, including bone marrow-derived cells, myoblasts, endogenous cardiac stem cells, umbilical cord-derived mesenchymal stem cells and embryonic cells.
In addition to direct tissue regenerative effects, stem cells also have clinical impact through the secretion of various growth factors and cytokines. Nutrient mediators secreted by stem cells improve cardiac function through mechanisms, such as attenuating tissue injury, inhibiting fibrotic remodeling, promoting angiogenesis, mobilizing host tissue stem cells, and reducing inflammation. The cardioprotective panel of stem cell secreted factors are considerable and include, but not limited to bFGF/FGF-2, IL-1β, IL-10, PDGF, VEGF, HGF, IGF-1, SDF-1, thymosin-β4, Wnt5a, Ang-1 and Ang-2, MIP-1, EPO and PDGF.
Cell therapy for cardiovascular disease therapy (Terashvili et al., 2019)
Our Services
CD BioSciences offers stem cell therapy development service for spinal cord injury based on our advanced technology and professional team. Our stem cell therapy development services are provided in CVDs included but not limited as follows:
- Acute Coronary Syndrome (ACS)
- Angina Pectoris
- Aortic Aneurysm
- Atherosclerosis
- Cardiac Arrhythmias
- Cardiac Fibrosis
- Stroke (Cerebrovascular Disease)
- Thrombosis
- Cardiomyopathy
- Congenital Heart Disease
- Coronary Artery Disease (CAD)
- Critical Limb Ischemia (CLI)
- Heart Failure
- Hypertension (High Blood Pressure)
- Valvular Heart Disease
- Vascular Diseases
- Ischemic Heart Disease (IHD)
- Myocardial Infarction (Heart Attack)
- Myocarditis
- Peripheral Artery Disease (PAD)
- Pulmonary Hypertension
- Raynaud's Disease
- Vasculitis
- Venous Insufficiency
As a pioneer in biotechnology, CD BioSciences has grown into one of the largest independent biotechnology companies in the world. CD BioSciences is committed to providing professional and efficient service to our customers around the world. If you are interested in our service, please contact us.
Reference
-
Terashvili, Maia, and Zeljko J Bosnjak. "Stem Cell Therapies in Cardiovascular Disease." Journal of cardiothoracic and vascular anesthesia vol. 33,1 (2019): 209-222.
For research use only, not for clinical use.
